{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:06:18Z","timestamp":1764079578440,"version":"3.40.5"},"reference-count":31,"publisher":"Archives of Endocrinology and Metabolism","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,5]]},"DOI":"10.20945\/2359-3997000000244","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T20:25:17Z","timestamp":1592339117000},"page":"243-250","source":"Crossref","is-referenced-by-count":10,"title":["Intrathyroid injection of dexamethasone inhibits Th2 cells in Graves\u2019 disease"],"prefix":"10.20945","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6077-3713","authenticated-orcid":false,"given":"Ke","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-3616","authenticated-orcid":false,"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9682-3612","authenticated-orcid":false,"given":"Bing-li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-7133","authenticated-orcid":false,"given":"Xiao-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-5245","authenticated-orcid":false,"given":"Xiao-ming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4477-3641","authenticated-orcid":false,"given":"Yun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"1","key":"key20200616162512_B1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000135626","article-title":"Immune-endocrine interactions in autoimmune thyroid diseases","volume":"15","author":"Klecha","year":"2008","unstructured":"1. Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation. 2008;15(1):68-75.","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"key20200616162512_B2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/SMJ.0b013e3181ddd952","article-title":"Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection","volume":"103","author":"Savvas","year":"2010","unstructured":"2. Savvas SP, Papakostas N, Giannaris M, Malaktari S, Koskinas J, Archimandritis AJ. Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection. South Med J. 2010;103(6):585-8.","journal-title":"South Med J"},{"issue":"6","key":"key20200616162512_B3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0019","article-title":"Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves\u2019 disease","volume":"156","author":"Inukai","year":"2007","unstructured":"3. Inukai Y, Momobayashi A, Sugawara N, Aso Y. Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves\u2019 disease. Eur J Endocrinol. 2007;156(6):623-30.","journal-title":"Eur J Endocrinol"},{"key":"key20200616162512_B4","doi-asserted-by":"crossref","DOI":"10.1186\/s13044-018-0046-9","article-title":"Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases","volume":"11","author":"Rydzewska","year":"2018","unstructured":"4. Rydzewska M, Jaromin M, Pasierowska IE, Stozek K, Bossowski A. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 2018;11:2.","journal-title":"Thyroid Res"},{"issue":"2","key":"key20200616162512_B5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.metabol.2010.02.002","article-title":"Cytokines (interferon-\u03b3 and tumor necrosis factor-\u03b1)-induced nuclear factor-\u03baB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone","volume":"60","author":"Antonelli","year":"2011","unstructured":"5. Antonelli A, Ferrari SM, Fallahi P, Piaggi S, Paolicchi A, Franceschini SS, et al. Cytokines (interferon-\u03b3 and tumor necrosis factor-\u03b1)-induced nuclear factor-\u03baB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone. Metabolism. 2011;60(2):277-83.","journal-title":"Metabolism"},{"issue":"6","key":"key20200616162512_B6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/er.2004-0023","article-title":"Insight into Graves\u2019 hyperthyroidism from animal models","volume":"26","author":"McLachlan","year":"2005","unstructured":"6. McLachlan SM, Nagayama Y, Rapoport B. Insight into Graves\u2019 hyperthyroidism from animal models. Endocr Rev. 2005;26(6): 800-32.","journal-title":"Endocr Rev"},{"issue":"1","key":"key20200616162512_B7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08916930601165388","article-title":"The balance shift in Th1\/Th2 related IL-12\/IL-5 cytokines in Graves\u2019 disease during methimazole therapy","volume":"40","author":"Molnar","year":"2007","unstructured":"7. Molnar I. The balance shift in Th1\/Th2 related IL-12\/IL-5 cytokines in Graves\u2019 disease during methimazole therapy. Autoimmunity. 2007;40(1):31-7.","journal-title":"Autoimmunity"},{"issue":"10","key":"key20200616162512_B8","first-page":"3602","article-title":"A possible role of immunoglobulin E in patients with hyperthyroid Graves\u2019 disease","volume":"84","author":"Sato","year":"1999","unstructured":"8. Sato A, Takemura Y, Yamada T, Ohtsuka H, Sakai H, Miyahara Y, et al. A possible role of immunoglobulin E in patients with hyperthyroid Graves\u2019 disease. J Clin Endocrinol Metab. 1999;84(10):3602-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20200616162512_B9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01824.x","article-title":"Detection and localization of chemokine gene expression in autoimmune thyroid disease","volume":"59","author":"Kemp","year":"2003","unstructured":"9. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003;59(2):207-13.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"key20200616162512_B10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-2008-1073151","article-title":"Circulating chemokines in patients with autoimmune thyroid diseases","volume":"40","author":"Domberg","year":"2008","unstructured":"10. Domberg J, Liu C, Papewalis C, Pfleger C, Xu K, Willenberg HS, et al. Circulating chemokines in patients with autoimmune thyroid diseases. Horm Metab Res. 2008;40(6):416-21.","journal-title":"Horm Metab Res"},{"issue":"2","key":"key20200616162512_B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03345149","article-title":"Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field","volume":"26","author":"Rotondi","year":"2003","unstructured":"11. Rotondi M, Lazzeri E, Romagnani P, Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest. 2003;26(2):177-80.","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"key20200616162512_B12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.yexcr.2011.04.007","article-title":"Peroxisome proliferator-activated receptor alpha agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves\u2019 disease","volume":"317","author":"Antonelli","year":"2011","unstructured":"12. Antonelli A, Ferrari SM, Frascerra S, Corrado A, Pupilli C, Bernini G, et al. Peroxisome proliferator-activated receptor alpha agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves\u2019 disease. Exp Cell Res. 2011;317(11):1527-33.","journal-title":"Exp Cell Res"},{"issue":"2","key":"key20200616162512_B13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-5793(96)00935-0","article-title":"Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes","volume":"394","author":"Kasai","year":"1996","unstructured":"13. Kasai K, Banba N, Motohashi S, Hattori Y, Manaka K, Shimoda SI. Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes. FEBS Lett. 1996;394(2):137-40.","journal-title":"FEBS Lett"},{"issue":"3","key":"key20200616162512_B14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1871520617666170719152349","article-title":"CCL2 is modulated by cytokines and PPAR-gamma in anaplastic thyroid cancer","volume":"18","author":"Ferrari","year":"2018","unstructured":"14. Ferrari SM, Elia G, Piaggi S, Baldini E, Ulisse S, Miccoli M, et al. CCL2 is modulated by cytokines and PPAR-gamma in anaplastic thyroid cancer. Anticancer Agents Med Chem. 2018;18(3):458-66.","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"key20200616162512_B15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/105072503321319413","article-title":"Graves\u2019 disease: the T(H)1\/T(H)2 paradigm versus the \u201chygiene\u201d hypothesis and defective immune regulation","volume":"13","author":"McLachlan","year":"2003","unstructured":"15. McLachlan SM. Graves\u2019 disease: the T(H)1\/T(H)2 paradigm versus the \u201chygiene\u201d hypothesis and defective immune regulation. Thyroid. 2003;13(2):127-8.","journal-title":"Thyroid"},{"issue":"1","key":"key20200616162512_B16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/thy.2009.0242","article-title":"Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin","volume":"20","author":"Yamazaki","year":"2010","unstructured":"16. Yamazaki K, Tanigawa K, Suzuki K, Yamada E, Yamada T, Takano K, et al. Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin. Thyroid. 2010;20(1):67-76.","journal-title":"Thyroid"},{"issue":"12","key":"key20200616162512_B17","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1210\/jc.2009-1252","article-title":"Prevention of relapse of Graves\u2019 disease by treatment with an intrathyroid injection of dexamethasone","volume":"94","author":"Mao","year":"2009","unstructured":"17. Mao XM, Li HQ, Li Q, Li DM, Xie XJ, Yin GP, et al. Prevention of relapse of Graves\u2019 disease by treatment with an intrathyroid injection of dexamethasone. J Clin Endocrinol Metab. 2009;94(12):4984-91.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20200616162512_B18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-11-0879","article-title":"Function of regulatory T-cells improved by dexamethasone in Graves\u2019 disease","volume":"166","author":"Hu","year":"2012","unstructured":"18. Hu Y, Tian W, Zhang LL, Liu H, Yin GP, He BS, et al. Function of regulatory T-cells improved by dexamethasone in Graves\u2019 disease. Eur J Endocrinol. 2012;166(4):641-6.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"key20200616162512_B19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.1995.03520340064038","article-title":"Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association","volume":"273","author":"Singer","year":"1995","unstructured":"19. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995;273(10):808-12.","journal-title":"JAMA"},{"issue":"10","key":"key20200616162512_B20","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1210\/jcem.86.10.7953","article-title":"Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes","volume":"86","author":"Garcia-Lopez","year":"2001","unstructured":"20. Garcia-Lopez MA, Sancho D, Sanchez-Madrid F, Marazuela M. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab. 2001;86(10):5008-16.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20200616162512_B21","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1210\/jc.2010-2905","article-title":"Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis","volume":"96","author":"Antonelli","year":"2011","unstructured":"21. Antonelli A, Ferrari SM, Frascerra S, Di Domenicantonio A, Nicolini A, Ferrari P, et al. Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab. 2011;96(6):1859-63.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20200616162512_B22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","unstructured":"22. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002;13(6):455-81.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"key20200616162512_B23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","article-title":"Chemokines as regulators of T cell differentiation","volume":"2","author":"Luther","year":"2001","unstructured":"23. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2(2):102-7.","journal-title":"Nat Immunol"},{"issue":"6","key":"key20200616162512_B24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1165\/rcmb.2013-0451OC","article-title":"Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations","volume":"51","author":"Martinu","year":"2014","unstructured":"24. Martinu T, Gowdy KM, Nugent JL, Sun J, Kinnier CV, Nelson ME, et al. Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations. Am J Respir Cell Mol Biol. 2014;51(6):810-21.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20200616162512_B25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2012.04.007","article-title":"Dexamethasone reduces bilirubin-induced toxicity and IL-8 and MCP-1 release in human NT2-N neurons","volume":"1458","author":"Almaas","year":"2012","unstructured":"25. Almaas R, Hanko E, Mollnes TE, Rootwelt T. Dexamethasone reduces bilirubin-induced toxicity and IL-8 and MCP-1 release in human NT2-N neurons. Brain Res. 2012;1458:12-7.","journal-title":"Brain Res"},{"key":"key20200616162512_B26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01199","article-title":"Plasmodium berghei NK65 in Combination with IFN-gamma Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK","volume":"8","author":"Zielinska","year":"2017","unstructured":"26. Zielinska KA, de Cauwer L, Knoops S, Van der Molen K, Sneyers A, Thommis J, et al. Plasmodium berghei NK65 in Combination with IFN-gamma Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK. Front Immunol. 2017;8:1199.","journal-title":"Front Immunol"},{"issue":"12","key":"key20200616162512_B27","article-title":"Dexamethasone inhibits activation of monocytes\/macrophages in a milieu rich in 27-oxygenated cholesterol","volume":"12","author":"Kim","year":"2007","unstructured":"27. Kim BY, Son Y, Lee J, Choi J, Kim CD, Bae SS, et al. Dexamethasone inhibits activation of monocytes\/macrophages in a milieu rich in 27-oxygenated cholesterol. PLoS One. 2007;12(12):e0189643.","journal-title":"PLoS One"},{"issue":"2","key":"key20200616162512_B28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4049\/jimmunol.1001794","article-title":"The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif","volume":"186","author":"Ishmael","year":"2011","unstructured":"28. Ishmael FT, Fang X, Houser KR, Pearce K, Abdelmohsen K, Zhan M, et al. The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif. J Immunol. 2011;186(2):1189-98.","journal-title":"J Immunol"},{"issue":"14","key":"key20200616162512_B29","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1074\/jbc.M605925200","article-title":"A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability","volume":"282","author":"Dhawan","year":"2007","unstructured":"29. Dhawan L, Liu B, Blaxall BC, Taubman MB. A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability. J Biol Chem. 2007:282(14):10146-52.","journal-title":"J Biol Chem"},{"issue":"1","key":"key20200616162512_B30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/endo.142.1.7904","article-title":"Glucocorticoids regulate plasma membrane potential during rat thymocyte apoptosis in vivo and in vitro","volume":"142","author":"Mann","year":"2001","unstructured":"30. Mann CL, Cidlowski JA. Glucocorticoids regulate plasma membrane potential during rat thymocyte apoptosis in vivo and in vitro. Endocrinology. 2001;142(1):421-9.","journal-title":"Endocrinology"},{"issue":"4","key":"key20200616162512_B31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MOP.0b013e32832cf824","article-title":"Autoimmune thyroid disease: unlocking a complex puzzle","volume":"21","author":"Brown","year":"2009","unstructured":"31. Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr. 2009;21(4):523-8.","journal-title":"Curr Opin Pediatr"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T20:25:54Z","timestamp":1592339154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020000300243&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6,5]]}},"alternative-id":["10.20945\/2359-3997000000244"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000244","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2020]]}}}